Sonoma Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 40.47 K | $49.78 K | 100.00% | 1.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 26.79 K | $32.95 K | 34.33% | 0.70% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 18.79 K | $23.11 K | 0.00% | 0.49% |
| MCKINLEY CARTER WEALTH SERVICES, INC. | 07/28/2026 | 11.19 K | $13.77 K | 0.00% | 0.29% |
| UBS GROUP AG | 08/13/2026 | 7.81 K | $9.60 K | 130,033.33% | 0.20% |
| GLOBAL RETIREMENT PARTNERS, LLC | 08/06/2026 | 2.55 K | $3.13 K | 100.00% | 0.07% |
| MORGAN STANLEY | 08/13/2026 | 2.00 K | $2.46 K | -0.20% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 500 | $615 | 0.00% | 0.01% |
| BARCLAYS PLC | 08/14/2026 | 459 | $565 | 100.00% | 0.01% |
| BLACKROCK, INC. | 08/07/2026 | 113 | $139 | 0.00% | 0.00% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 100 | $123 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 08/12/2026 | 15 | $18 | 100.00% | 0.00% |
| QUAKER WEALTH MANAGEMENT, LLC | 07/24/2026 | 3 | $4 | 0.00% | 0.00% |
| DANSKE BANK A/S | 08/10/2026 | 1 | $1 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| US BANCORP \DE\ | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 0 | $0 | -100.00% | 0.00% |
Sonoma Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 24 institutional investors and hedge funds held shares of Sonoma Pharmaceuticals Inc.. The most heavily invested institutionals were:
RENAISSANCE TECHNOLOGIES LLC: 40,468
GEODE CAPITAL MANAGEMENT, LLC: 26,787
VANGUARD CAPITAL MANAGEMENT LLC: 18,787
McKinley Carter Wealth Services, Inc.: 11,193
UBS Group AG: 7,808
Global Retirement Partners, LLC: 2,548
2.88% of Sonoma Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 132.10 K shares in the last 24 months. This purchase volume represents approximately $332.90 K in transactions.